Sorted By:

Relevance


340B Spotlight: Program continues to grow with no end in sight

PhRMA  |  Blog Post

report-to-the-congress-overview-of-the-340b-drug-pricing-program.pdf?
http://catalyst.phrma.org/340b-spotlight-program-continues-to-grow-with-no-end-in-sight

PhRMA Statement of Support for Introduction of the Customs Facilitation and Trade Enforcement Reauthorization Act of 2009

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-of-support-for-introduction-of-the-customs-facilitation-and-trade-enforcement-reauthorization-act-of-2009

Finding cures for incurable diseases

PhRMA  |  Blog Post

To learn more about innovative therapies in the biopharmaceutical pipeline, click here. and learn more about lupus here.
http://catalyst.phrma.org/finding-cures-for-incurable-diseases

5 Things to Know About the CMS Part D Data Release

PhRMA  |  Blog Post

Publicly-available reports suggest more than half of the medicines on the list are currently off patent or are expected to lose patent protection by 2016.
http://catalyst.phrma.org/5-things-to-know-about-the-cms-part-d-data-release

Senior Director – Policy and Research

PhRMA  |  PhRMA Career

The preferred candidate will bring substantive health care policy analysis experience, ideally in a legislative setting, as well as exceptional written and verbal communication skills, the ability to analyze, draft / amend legislative text, expertise in reviewing and interpreting in-depth policy analyses including trend reports and fiscal impact statements, and be focused, organized, detail-oriented, responsive and diplomatic.
https://www.phrma.org

Consumers Still Pay Bigger Share For Healthcare Than Government And Businesses

Access Better Coverage  |  From Our Network

”Meanwhile, household budgets saw premiums swallow more of their income in 2013 compared with 2010, the Commonwealth Fund reported.
http://www.accessbettercoverage.org/social-news/consumers-still-pay-bigger-share-for-healthcare-than-government-and-businesses

Deputy Vice President – Policy and Research

PhRMA  |  PhRMA Career

The preferred candidate will bring substantive policy development and analytic experience, ideally in a legislative setting or federal agency policy office, as well as exceptional written and verbal communication skills, expertise in reviewing and interpreting in-depth policy analyses including trend reports and fiscal impact statements, and be focused, organized, detail-oriented, responsive and diplomatic. 
https://www.phrma.org

Seniors Rate Part D Highly on Many Measures

Chartpack  |  From Our Network

Medicare Part D beneficiaries report that their plans are affordable and work well.
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicare/seniors-rate-part-d-highly-on-many-measures

Some Insured Patients Still Skipping Care Because Of High Costs

Access Better Coverage  |  From Our Network

"One in four adults who were fully insured for the whole year still reported they went without some needed medical care because they couldn't afford it," Mitts says.
http://www.accessbettercoverage.org/social-news/some-insured-patients-still-skipping-care-because-of-high-costs

PhRMA, member companies and NIH create public-private partnership for immuno-oncology

PhRMA  |  Blog Post

As PhRMA reported in June, there are currently more than 240 immuno-oncology medicines and vaccines in development to help treat cancer.
http://catalyst.phrma.org/phrma-member-companies-and-nih-create-public-private-partnership-for-immuno-oncology

Why drug importation threatens patient safety

PhRMA  |  Blog Post

As CNN reported, quoting an online seller from Pakistan, “We sell all over the world, to America, Europe, China, Iran and Iraq.
http://catalyst.phrma.org/why-drug-importation-threatens-patient-safety

PhRMA letter to Puerto Rico Secretary of Economic Development and Commerce

PhRMA  |  Press Release

Facilitating Efficient Transportation Alleviating congestion and blockages on roads and at port terminals would facilitate the transportation of goods and materials on and off the island.
https://www.phrma.org/press-release/phrma-letter-to-puerto-rico-secretary-of-economic-development-and-commerce

More than 85 medicines in development for Alzheimer’s disease

PhRMA  |  Blog Post

A list of medicines in development can be found here.
http://catalyst.phrma.org/more-than-85-medicines-in-development-for-alzheimers-disease

PhRMA Statement on Appointment of White House Health Czar

PhRMA  |  Press Release

Industry-wide research and investment reached a record $58.8 billion in 2007.
https://www.phrma.org/press-release/phrma-statement-on-appointment-of-white-house-health-czar

Free Trade Agreements May Be Good For Your Health

PhRMA  |  Blog Post

The Geneva Network report is the latest of a number of reports that compellingly refute many of the arguments against including biopharmaceutical IP provisions in the TPP that reflect U.S. standards.
http://catalyst.phrma.org/free-trade-agreements-may-be-good-for-your-health

PhRMA Statement on the Senate Finance Committee Proposal

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-the-senate-finance-committee-proposal

Prescription Drug Misuse, Abuse & Disposal

PhRMA  |  From PhRMA

In 2014, more than 6.5 million Americans over age 12 reported abusing prescription drugs during the previous month and 4.3 million reported abusing prescription pain relievers.
https://www.phrma.org/advocacy/safety/prescription-misuse-abuse

Treatment Adherence Improved for Veterans After Enrolling in Part D

Chartpack  |  From Our Network

Beneficiaries whose primary drug coverage was through the VA in 2003 and through Part D in 2006 reported lower rates of non-adherence to therapy after enrolling in Part D.
http://chartpack.phrma.org/programs-chartpack/medicines-in-veterans-affairs/treatment-adherence-improved-for-veterans-after-enrolling-in-part-d

STEMming the Tide

PhRMA  |  Blog Post

One of the report's findings was that our biosciences talent pool is limited, and we are in need of a renewed commitment to STEM education.
http://catalyst.phrma.org/stemming-the-tide

PhRMA CEO Statement Following Meeting With President Trump

PhRMA  |  Blog Post

To do this, we need to reform existing laws and regulations that are currently preventing private companies from negotiating better deals and paying for medicines based on the value they provide to patients and our health care system.
http://catalyst.phrma.org/phrma-ceo-statement-following-meeting-with-president-trump

PhRMA Applauds Nomination of Kathleen Sebelius as HHS Secretary

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-applauds-nomination-of-kathleen-sebelius-as-hhs-secretary

4 facts on why drug importation is bad for patients

PhRMA  |  Blog Post

An October 2014 National Association of Boards of Pharmacy (NABP) survey of online drug sellers revealed that 96 percent of over 10,000 internet drug outlets “were operating out of compliance with U.S. pharmacy laws and practice standards.
http://catalyst.phrma.org/4-facts-on-why-drug-importation-is-bad-for-patients

Release: Medicines In Development for Rare Diseases

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.3 billion in 2009.
https://www.phrma.org/press-release/release-medicines-in-development-for-rare-diseases

PhRMA Applauds Bipartisan Senate Support for Strong Intellectual Property Protections in the Trans-Pacific Partnership Agreement

PhRMA  |  Press Release

Industry-wide research and investment reached a record $67.4 billion in 2010.
https://www.phrma.org/press-release/phrma-applauds-bipartisan-senate-support-for-strong-intellectual-property-protections-in-the-trans-pacific-partnership-agreement

New analysis: More than half of patients’ out-of-pocket spending for brand medicines is based on full list price

PhRMA  |  Blog Post

Read the full analysis here.
http://catalyst.phrma.org/new-analysis-more-than-half-of-patients-out-of-pocket-spending-for-brand-medicines-is-based-on-full-list-price

You have reviewed the first 375 results out of 1032. Each page contains 25 results. You're on page 15.

prev 13 14 15 16 17 18 next